Showing 1 - 7 results of 7 for search 'Jaimie Z. Shing', query time: 0.05s Refine Results
  1. 1
    2013 Trends in anogenital warts incidence: Potential impact of human papillomavirus vaccination, TennCare 2006–2015

    2013 Trends in anogenital warts incidence: Potential impact of human papillomavirus vaccination, TennCare 2006–2015 by Jaimie Z. Shing, Marie Griffin, Manideepthi Pemmaraju, Edward Mitchel, Pamela Hull

    Published 2018-06-01
    Get full text
    Article
  2. 2
    Racial Disparities among Asian American, Native Hawaiian, and Other Pacific Islander Patients with Cancer Who Refuse Recommended Radiation Therapy or Surgery

    Racial Disparities among Asian American, Native Hawaiian, and Other Pacific Islander Patients with Cancer Who Refuse Recommended Radiation Therapy or Surgery by Brianna Lau, Paul Tominez, Jaimie Z. Shing, Jacqueline B. Vo, Erqi Pollom, Kekoa Taparra

    Published 2023-06-01
    Get full text
    Article
  3. 3
    The Impact of the Human Papillomavirus Vaccine on High-Grade Cervical Lesions in Urban and Rural Areas: An Age–Period–Cohort Analysis

    The Impact of the Human Papillomavirus Vaccine on High-Grade Cervical Lesions in Urban and Rural Areas: An Age–Period–Cohort Analysis by Jaimie Z. Shing, Alicia Beeghly-Fadiel, Marie R. Griffin, Rachel S. Chang, Staci L. Sudenga, James C. Slaughter, Manideepthi Pemmaraju, Edward F. Mitchel, Pamela C. Hull

    Published 2021-08-01
    Get full text
    Article
  4. 4
    Racial Disparities in Brachytherapy Treatment among Women with Cervical and Endometrial Cancer in the United States

    Racial Disparities in Brachytherapy Treatment among Women with Cervical and Endometrial Cancer in the United States by Kekoa Taparra, Brandon I. Ing, Agnes Ewongwo, Jacqueline B. Vo, Jaimie Z. Shing, Megan Y. Gimmen, Kiana M. K. Keli‘i, Jason Uilelea, Erqi Pollom, Elizabeth Kidd

    Published 2023-04-01
    Get full text
    Article
  5. 5
    Trends in anogenital wart incidence among Tennessee Medicaid enrollees, 2006–2014: The impact of human papillomavirus vaccination

    Trends in anogenital wart incidence among Tennessee Medicaid enrollees, 2006–2014: The impact of human papillomavirus vaccination by Jaimie Z. Shing, Pamela C. Hull, Yuwei Zhu, Julia W. Gargano, Lauri E. Markowitz, Angela A. Cleveland, Manideepthi Pemmaraju, Ina U. Park, Erin Whitney, Edward F. Mitchel, Marie R. Griffin

    Published 2019-06-01
    Get full text
    Article
  6. 6
    Measurement of provider fidelity to immunization guidelines: a mixed-methods study on the feasibility of documenting patient refusals of the human papillomavirus vaccine

    Measurement of provider fidelity to immunization guidelines: a mixed-methods study on the feasibility of documenting patient refusals of the human papillomavirus vaccine by Rachel S. Chang, Jaimie Z. Shing, Jennifer C. Erves, Liping Du, Tatsuki Koyama, Stephen Deppen, Alyssa B. Rentuza, Caree McAfee, Christine Stroebel, Janet Cates, Lora Harnack, David Andrews, Robert Bramblett, Pamela C. Hull

    Published 2022-12-01
    Get full text
    Article
  7. 7
    HPV16 infection decreases vaccine-induced HPV16 antibody avidity: the CVT trial

    HPV16 infection decreases vaccine-induced HPV16 antibody avidity: the CVT trial by Sabrina H. Tsang, John T. Schiller, Carolina Porras, Troy J. Kemp, Rolando Herrero, John Schussler, Monica S. Sierra, Bernal Cortes, Allan Hildesheim, Douglas R. Lowy, Ana Cecilia Rodríguez, Byron Romero, Nicolas Çuburu, Jaimie Z. Shing, Ligia A. Pinto, Joshua N. Sampson, Aimée R. Kreimer, on behalf of the Costa Rica HPV Vaccine Trial Group

    Published 2022-03-01
    Get full text
    Article

Search Tools: